How much is Scribe Biosciences worth in 2026?

Scribe Biosciences has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has Scribe Biosciences raised?

Scribe Biosciences has raised N/A in total funding across 1 funding rounds.

Scribe Biosciences

Other Devices and Supplies

Scribe Biosciences valuation and funding history | Last updated: December 1, 2021 | 1 funding rounds

Current Valuation

N/A

As of December 1, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC

Amount undisclosed

Last Funding

Dec 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 1, 2021	Early Stage VC	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Scribe Biosciences is currently valued at N/A as of December 1, 2021.

Track Scribe Biosciences Valuation Updates

Get notified when Scribe Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Scribe Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Scribe Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Scribe Biosciences Worth in 2026?

Scribe Biosciences is a leading private company in the Other Devices and Supplies sector. Track Scribe Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Scribe Biosciences Valuation is Determined

Private company valuations like Scribe Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.